Christina A Brezing MD
Addiction
Clinical Fellow in Psychiatry, Massachusetts General Hospital
Join to View Full Profile
55 Fruit St.Massachusetts General HospitalBoston, MA 02114
Phone+1 617-726-2000
Dr. Brezing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 2010 - 2014
University of Florida College of MedicineClass of 2010
New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteFellowship, Addiction Psychiatry
Certifications & Licensure
NY State Medical License 2014 - 2027
MA State Medical License 2012 - 2015
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
Clinical Trials
- Lorcaserin for Cannabis Use Disorder Start of enrollment: 2019 Aug 01
Publications & Presentations
PubMed
- Extended-Release Mixed Amphetamine Salts for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder: A Pilot, Randomized Double-Blind, Place...Frances R Levin, John J Mariani, Martina Pavlicova, C Jean Choi, Cale Basaraba
Journal of Attention Disorders. 2024-09-01 - 1 citationsOpioid-induced hypogonadism in opioid use disorder, its role in negative reinforcement, and implications for treatment and retention.Avery F McGuirt, Christina A Brezing
The American Journal of Drug and Alcohol Abuse. 2024-03-03 - 1 citationsMixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial.Kenneth M Carpenter, C Jean Choi, Cale Basaraba, Martina Pavlicova, Daniel J Brooks
Experimental and Clinical Psychopharmacology. 2024-02-01
Press Mentions
New Insights on Substance Use DisordersJuly 28th, 2017- Introduction: Cautions, Considerations, and Treatment StrategiesJune 30th, 2017
Expert Availability: NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine Experts to Present at the 2017 American Psychiatric Association (APA) MeetingMay 18th, 2017
Grant Support
- A Randomized, Controlled Trial of Sublingual Buprenorphine through Telemedicine vs In-Person Care as Usual in the Treatment of Opioid Use DisorderNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
